RESOURCE LIBRARY 

This information is for informational purposes only.  Please refer to the Impavido Product package for approved indications and prescribing information

Studies/Info on Leishmania
Studies/Info on PAM
Studies/Info on Acanthamoeba Keratitis
Videos on Leishmania
Videos on PAM
Videos on Acanthamoeba Keratitis

 Impavido® (miltefosine) is an FDA-approved treatment for cutaneous,  mucosal and visceral leishmaniasis in patients 12 years of age and older. PLEASE SEE FULL PRESCRIBING INFO